Sam Craft

Sam Craft

Auto-generated profile, based on publicly available information

Sam Craft

Department of Psychology University of Bath Bath UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2020 in Addiction
Verified
Journal Article
Open access
PDF file
TFTom P. Freeman
Tom P. Freeman
SCSam Craft
Sam Craft
JWJack Wilson
Jack Wilson
SSStephan Stylianou
Stephan Stylianou
MEMahmoud ElSohly
Mahmoud ElSohly
MLMichael Lynskey
Michael Lynskey
Background and aims: Cannabis products with high delta‐9‐tetrahydrocannabinol (THC) concentrations carry an increased risk of addiction and mental health disorders, while it has been suggested that cannabidiol (CBD) may moderate the effects of THC. This study aimed to systematically review and meta‐analyse changes in THC and CBD concentrations in cannabis over time (PROSPERO registration: CRD42019130055).Design: Embase, MEDLINE® and Epub Ahead of Print, In‐Process and Other Non‐Indexed Citations and Daily, Global Health, PsycINFO and Scopus were searched from inception to 27/03/2019 for observational studies reporting changes in mean THC and/or CBD concentration in cannabis over at least three annual time points. Searches and extraction were conducted by two independent reviewers. Random effects meta‐regression models estimated annual changes in THC and CBD for each product within each study; these estimates were pooled across studies in random effects models.Results: We identified 12 eligible studies from the USA, UK, Netherlands, France, Denmark, Italy and New Zealand. For all herbal cannabis, THC concentrations increased by 0.29% each year (95% CI: 0.11, 0.47), P < 0.001 based on 66 747 cannabis samples from eight studies, 1970–2017. For cannabis resin, THC concentrations increased by 0.57% each year (95% CI: 0.10, 1.03), P = 0.017 based on 17 371 samples from eight studies, 1975–2017. There was no evidence for changes in CBD in herbal cannabis [−0.01% (95% CI: −0.02, 0.01), P = 0.280; 49 434 samples from five studies, 1995–2017] or cannabis resin [0.03% (95% CI: −0.11, 0.18), P = 0.651; 11 382 samples from six studies, 1992–2017]. Risk of bias was low apart from non‐random sampling in most studies. There was evidence of moderate to substantial heterogeneity.Conclusions: Concentrations of delta‐9‐tetrahydrocannabinol (THC) in international cannabis markets increased from 1970 to 2017 while cannabidiol (CBD) remained stable. Increases in THC were greater in cannabis resin than herbal cannabis. Rising THC in herbal cannabis was attributable to an increased market share of high‐THC sinsemilla relative to low‐THC traditional herbal cannabis.

13 October 2019 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
SCSam Craft
Sam Craft
AWAdam Winstock
Adam Winstock
JFJason Ferris
Jason Ferris
CMClare Mackie
Clare Mackie
MLMichael T. Lynskey
Michael T. Lynskey
TFTom P. Freeman
Tom P. Freeman
Background: As new cannabis products and administration methods proliferate, patterns of use are becoming increasingly heterogeneous. However, few studies have explored different profiles of cannabis use and their association with problematic use.Methods: Latent class analysis (LCA) was used to identify subgroups of past-year cannabis users endorsing distinct patterns of use from a large international sample (n = 55 240). Past-12-months use of six different cannabis types (sinsemilla, herbal, hashish, concentrates, kief, edibles) were used as latent class indicators. Participants also reported the frequency and amount of cannabis used, whether they had ever received a mental health disorder diagnosis and their cannabis dependence severity via the Severity of Dependence Scale (SDS).Results: LCA identified seven distinct classes of cannabis use, characterised by high probabilities of using: sinsemilla & herbal (30.3% of the sample); sinsemilla, herbal & hashish (20.4%); herbal (18.4%); hashish & herbal (18.8%); all types (5.7%); edibles & herbal (4.6%) and concentrates & sinsemilla (1.7%). Relative to the herbal class, classes characterised by sinsemilla and/or hashish use had increased dependence severity. By contrast, the classes characterised by concentrates use did not show strong associations with cannabis dependence but reported greater rates of ever receiving a mental health disorder diagnosis.Conclusions: The identification of these distinct classes underscores heterogeneity among cannabis use behaviours and provides novel insight into their different associations with addiction and mental health.

10 September 2024 in Addiction
Verified
Journal Article
Open access
SCSam Craft
Sam Craft
PSPeter Sunderland
Peter Sunderland
MMMolly F. Millea
Molly F. Millea
CPChristopher R. Pudney
Christopher R. Pudney
OSOliver B. Sutcliffe
Oliver B. Sutcliffe
TFTom P. Freeman
Tom P. Freeman
Background and aims: In the United Kingdom and internationally, synthetic cannabinoids (SCs) are a common adulterant in illicitly sourced vaping products. Recently, their use is increasingly being linked to severe health effects, particularly among children. Here, we aimed to conduct the first detection and quantification of SCs in illicit disposable vaping products.Methods: A cross‐section of seven illicitly sourced disposable vape samples that were initially sold as cannabis products was submitted for analysis by a single individual presenting to a drug and alcohol service in the United Kingdom. Qualitative and quantitative analyses of these samples were conducted using nuclear magnetic resonance and gas chromatography/electron ionization‐mass spectrometry.Results: Qualitative analysis identified the SC 5F‐MDMB‐PICA in all seven samples, in the absence of any other pharmacologically active compounds. Quantitative analysis revealed that the median concentration of 5F‐MDMB‐PICA was 0.85 mg/ml (range = 0.59–1.63). The external appearance of these vape samples closely resembled regulated vaping products, and the presence of SCs was not identifiable by any labelling or packaging.Conclusions: The SC 5F‐MDMB‐PICA was detected at a median concentration of 0.85 mg/ml in seven disposable vapes which were illegally sourced in the United Kingdom, were mis‐sold as cannabis products and closely resembled legal, regulated products.

7 October 2023 in International Journal of Drug Policy
Verified
Journal Article
Open access
SCSam Craft
Sam Craft
AAAlice Austin
Alice Austin
TTTom Tooth
Tom Tooth
CGCatherine Glover
Catherine Glover
TGTina Garrett
Tina Garrett
TFTom P Freeman
Tom P Freeman
Synthetic cannabinoids (i.e. Spice) are a major public health problem in UK prisons, however, research in this area is limited. Here we aimed to draw comparisons between people with and without experience of using synthetic cannabinoids in prison, to characterise the features of, and motivations for use within this setting and evaluate support for different treatment interventions. Questionnaires were administered to 122 people in a category-B prison for adult males in England between July 2022 and March 2023. Participants were asked questions related to their sociodemographic and custodial characteristics, use of synthetic cannabinoids (and other drugs) inside and outside of prison and psychological distress was measured via the Brief Symptom Inventory (BSI-18). Those that had ever used synthetic cannabinoids in prison completed additional questions related to features of use, motivations for use and support for various interventions. In total 46.7 % (n = 57) of participants reported use of synthetic cannabinoids in prison and this group experienced significantly greater levels of psychological distress compared to those reporting no use (mean (± standard deviation) BSI-18 scores = 23.7 (±16.7) vs 12.8 (±13.6), p < 0.001). Participants mostly reported using paper-based preparations (77.4 %) and use via e-cigarettes (75.9 %). The most strongly endorsed motivations for use included to alleviate boredom (91.1 % strongly agree/agree), to make the sentence pass faster (89.3 % strongly agree/agree) and to cope with stress (80.4 % strongly agree/agree). The interventions that received most support were strategies to better manage time and medication to manage withdrawal. The use of synthetic cannabinoids in UK prisons typically involves the use of paper-based preparations via e-cigarettes, and use is associated with greater levels of psychological distress. Motivations for use were mostly pragmatic (e.g. to alleviate boredom or cope with stress) and interventions should prioritise increasing the time individuals spend out of cells and in meaningful activity.

17 September 2021 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
SCSam Craft
Sam Craft
JFJason A. Ferris
Jason A. Ferris
MBMonica J. Barratt
Monica J. Barratt
LMLarissa J. Maier
Larissa J. Maier
MLMichael T. Lynskey
Michael T. Lynskey
TFTom P. Freeman
Tom P. Freeman
Synthetic cannabinoid receptor agonists (SCRAs) may be used as an alternative to natural cannabis; however, they may carry a greater risk of problematic use and withdrawal. This study aimed to characterise the withdrawal symptom profile of SCRAs and compare their profile of effect with high-potency herbal cannabis. Global Drug Survey data (2015 and 2016) were used to access a clinically relevant sample of people reporting use of SCRAs >10 times in the past 12-months, a previous SCRA quit attempt, and lifetime use of high-potency herbal cannabis. Participants completed an 11-item SCRA withdrawal symptom checklist and compared SCRAs and high-potency herbal cannabis on their onset and duration of effects, speed of the development of tolerance, severity of withdrawal, and difficulty with dose titration. Participants (n = 284) reported experiencing a mean of 4.4 (95% CI: 4.1, 4.8) withdrawal symptoms after not using SCRAs for >1 day; most frequently reported were sleep issues (59.2%), irritability (55.6%), and low mood (54.2%). Withdrawal symptoms were significantly associated with frequency (>51 vs. 11–50 times per year: IRR = 1.43, 95% CI: 1.16, 1.77, p = 0.005) and quantity (grams per session: IRR = 1.13, 95% CI: 1.05, 1.22, p = 0.001) of SCRA use. Compared to high-potency herbal cannabis, SCRAs were rated as having a faster onset and shorter duration of effects, faster development of tolerance, and more severe withdrawal (p’s < 0.001). In conclusion, SCRA withdrawal symptoms are more likely to occur after greater SCRA exposure. The effects of SCRA indicate a more severe withdrawal syndrome and a greater risk of problematic use than natural cannabis.

26 June 2025 in Addiction
Verified
Journal Article
Open access
GCGyles E. Cozier
Gyles E. Cozier
MGMatthew Gardner
Matthew Gardner
SCSam Craft
Sam Craft
MSMartine Skumlien
Martine Skumlien
JSJack Spicer
Jack Spicer
CPChristopher R. Pudney
Christopher R. Pudney
Background and aims: People who use synthetic cannabinoids (SCs) report debilitating side effects and withdrawal symptoms, coupled with dependence. In the UK, SC use was believed to be largely restricted to prison, where they are the most common drug and associated with nearly half of non‐natural deaths, or poly‐drug users in the community who are also likely to be homeless. However, national media reporting has increasingly identified cases of children collapsing in schools, which are claimed to be associated with vaping and putatively involving a drug such as delta‐9‐tetrahydrocannabinol (THC) or SCs. We therefore conducted the first study to identify and quantify SCs in e‐cigarettes routinely collected from schools in England.Design: E‐cigarette and e‐liquid samples seized by teachers in schools were identified through engagement with police forces and city councils in England. We sought agreements across broad geographical areas and based on acquiring the relevant approvals at a local level. Sample bias is considered in the analysis and reporting.Setting and cases: Samples were submitted from 27 secondary (age 11–18) schools from geographically distinct regions of England, representing a broad range of social metrics (free school meals, persistent absenteeism and special educational needs). All submitted samples were anonymised and no identifying information was collected. Analysis of samples was conducted both in a laboratory setting and in‐field at local police stations.Measurements: Qualitative gas chromatography–mass spectrometry and liquid chromatography–mass spectrometry were used to identify SCs and THC in e‐cigarettes/liquid, with concentration measured by quantitative nuclear magnetic resonance spectroscopy. A subset of samples was screened for SCs and THC using a portable detector based on combined fluorescence and photochemical discrimination.Findings: E‐cigarettes containing SC were identified in 77.8% of all participating schools and were detected in 17.4% of all samples seized. These were almost entirely in refillable devices and liquid bottles, with very few in single use products. The percentage of SC e‐cigarettes in schools positively correlated with the fraction of pupils eligible for free school meals, a social deprivation metric (Pearson's correlation r = 0.65 and P = 0.003). Positive samples contained a median SC concentration of 0.42 (interquartile range = 0.77) mg mL−1 with a maximum of 3.6 mg mL−1. In contrast, few samples contained THC (1.2%).Conclusions: E‐cigarettes containing synthetic cannabinoids were identified in three quarters of 27 secondary schools in England that were sampled.